Preoperative Oral Carbohydrate Improved Postoperative Insulin Resistance in Rats through the PI3K/AKT/mTOR Pathway

被引:4
|
作者
Wang, Zhiguo [1 ]
Liu, Yiqing [2 ]
Li, Qi [1 ]
Ruan, Canping [1 ]
Wu, Bin [3 ]
Wang, Qiang [4 ]
Hu, Zhiqian [1 ]
Qin, Huanlong [5 ]
机构
[1] Second Mil Med Univ, Dept Gen Surg, Shanghai Chang Zheng Hosp, Shanghai, Peoples R China
[2] Second Mil Med Univ, Lib, Shanghai, Peoples R China
[3] Second Mil Med Univ, Dept Thorac Surg, Shanghai Chang Zheng Hosp, Shanghai, Peoples R China
[4] Shanghai Zhabei Cent Hosp, Dept Gen Surg, Shanghai, Peoples R China
[5] Tongji Univ, Dept Gen Surg, Peoples Hosp 10, Shanghai 200092, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2015年 / 21卷
基金
中国国家自然科学基金;
关键词
Leucine; Insulin Resistance; Perioperative; Phosphoinositide Phospholipase C; TOR Serine-Threonine Kinases; RANDOMIZED CLINICAL-TRIAL; MAMMALIAN PROTEIN; GLUCOSE-POLYMER; LEUCINE; METABOLISM; LIVER;
D O I
10.12659/MSM.891063
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Preoperative oral carbohydrate (OCH) improves postoperative insulin resistance (PIR) and insulin sensitivity. However, the exact mechanisms involved in the improvement of PIR with respect to preoperative OCH are still not clear. The aim of this study was to investigate the involvement of preoperative OCH and PI3K/AKT/mTOR pathway in reducing PIR in rats. Material/Methods: Forty male Sprague-Dawley rats were randomly assigned to PreOp, glucose, saline, and fasting groups. Rats in the PreOp, glucose, and saline groups received OCH, 5% glucose solution, and saline, respectively. Rats in the fasting group did not receive anything but were fasted 3 h before surgery. Blood glucose, insulin and leucine levels, and insulin resistance, secretion, and sensitivity indexes were measured before and after surgery. mRNA and protein (total and phosphorylated) levels of mTOR, IRS-1, PI3K, PKB/AKT, and GlUT4 were measured using real-time polymerase chain reaction and Western blot in skeletal muscles. Results: In the PIR experiment, blood glucose, serum insulin, insulin resistance, and serum leucine levels were all significantly lower in the PreOp group than in the other 3 groups (P<0.05) after surgery. HOMA-ISI were higher in the PreOp group vs the other 3 groups after surgery (P<0.05), and HOMA-b in the PreOp group was higher than that in the other 3 groups at 30 and 120 min after surgery. Additionally, post-operative phosphorylated IRS-1, PI3K, and AKT protein levels were significantly higher in the PreOp group than in the other 3 groups (P<0.05), but no significant differences were observed in their respective protein levels (P>0.05). Conclusions: OCH decreases postoperative insulin resistance and improves postoperative insulin sensitivity in skeletal muscles through the PI3K/AKT/mTOR pathway.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 50 条
  • [11] THE PI3K/AKT MTOR PATHWAY IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T.
    Tyler, W.
    Gangoli, N.
    Gokina, P.
    Kim, H.
    Covey, M.
    Levison, S.
    GLIA, 2009, 57 (13) : S20 - S20
  • [12] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [13] PI3K/AKT/mTOR
    Umemura, Shigeki
    Goto, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
  • [14] The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway
    Cai, Yu
    Wang, Ying
    Zhi, Fei
    Xing, Qi-Chang
    Chen, Yun-Zhong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [15] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
  • [16] Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
    Burris, Howard A., III
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 829 - 842
  • [17] Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
    Howard A. Burris
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 829 - 842
  • [18] ACTIVATION OF RENAL PI3K/Akt/mTOR SIGNALING PATHWAY IN OBSTRUCTIVE UROPATHY IN RATS
    Ma, Seong Kwon
    Joo, Soo Yeon
    Kim, Chang Seong
    Choi, Joon Seok
    Bae, Eun Hui
    Lee, JongUn
    Kim, Soo Wan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 109 - 109
  • [19] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
    Barra, Fabio
    Desideri, Lorenzo Ferro
    Ferrero, Simone
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3626 - 3627
  • [20] Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
    LoRusso, Patricia Mucci
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3803 - +